First African Genome Study Identifies Two Genetic Variants Linked to Breast Cancer
Researchers in South Africa uncover novel genetic risk factors, highlighting the need for ancestry-specific tools and precision medicine.
Overview
- The Sydney Brenner Institute for Molecular Bioscience conducted the first genome-wide association study (GWAS) of breast cancer in African women living on the continent.
- Two genetic variants, RAB27A and USP22, were identified as being linked to breast cancer in black South African women, representing a significant advance in understanding breast cancer biology in African populations.
- Existing polygenic risk scores, developed using European populations, were found to perform poorly in African contexts, underscoring the need for ancestry-specific risk prediction tools.
- If further validated, RAB27A and USP22 could serve as targets for precision cancer therapies and biomarkers for identifying aggressive breast cancer cases.
- The study emphasizes the underrepresentation of African populations in genomic research and calls for investment in African-centered genomics to address health disparities and improve disease outcomes.